Patients treated with oxaliplatin are at risk for thrombocytopenia caused by multiple drug-dependent antibodies

Blood. 2018 Mar 29;131(13):1486-1489. doi: 10.1182/blood-2017-10-812461. Epub 2018 Feb 12.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Autoantibodies* / blood
  • Autoantibodies* / immunology
  • Colonic Neoplasms* / blood
  • Colonic Neoplasms* / drug therapy
  • Colonic Neoplasms* / immunology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Oxaliplatin* / administration & dosage
  • Oxaliplatin* / adverse effects
  • Purpura, Thrombocytopenic, Idiopathic* / blood
  • Purpura, Thrombocytopenic, Idiopathic* / chemically induced
  • Purpura, Thrombocytopenic, Idiopathic* / immunology
  • Stomach Neoplasms* / blood
  • Stomach Neoplasms* / drug therapy
  • Stomach Neoplasms* / immunology

Substances

  • Autoantibodies
  • Oxaliplatin